Evidence of platelet activation due to tirofiban-dependent platelet antibodies: double trouble.
Dunkley
S
S
Lindeman
R
R
Evans
S
S
Casten
R
R
Jepson
N
N
D000368:Aged; D000906:Antibodies / Q000737:chemistry*; D001792:Blood Platelets / Q000276:immunology*; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis; D015539:Platelet Activation; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000378:metabolism; D013921:Thrombocytopenia / Q000473:pathology; D013997:Time Factors; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology*
D000906:Antibodies; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D012701:Serotonin; D014443:Tyrosine; D000077466:Tirofiban